Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Expert Opinion on Therapeutic Targets|April 2, 2019
Heat shock factor 1 (HSF1)-targeted anticancer therapeutics: overview of current preclinical progressToshiki Kijima, Thomas Prince, Len Neckers, et al.Biochemical and Biophysical Research Communications|May 11, 2005
Evidence for chaperone heterocomplexes containing both Hsp90 and VCPThomas Prince, Jieya Shao, Robert L Matts, et al.Plos One|March 11, 2014
Hsp90-dependent assembly of the DBC2/RhoBTB2-Cullin3 E3-ligase complexJacob R Manjarrez, Liang Sun, Thomas Prince, et al.Plos One|July 7, 2012
mTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesisShiuh-Dih Chou, Thomas Prince, Jianlin Gong, et al.Plos One|April 4, 2015
Scavenger receptor SREC-I mediated entry of TLR4 into lipid microdomains and triggered inflammatory cytokine release in RAW 264.7 cells upon LPS activationAyesha Murshid, Jianlin Gong, Thomas Prince, et al.Biochimica Et Biophysica Acta|April 17, 2012
Characterization of the interaction of Aha1 with components of the Hsp90 chaperone machine and client proteinsLiang Sun, Thomas Prince, Jacob R Manjarrez, et al.Nature Reviews. Cancer|May 31, 2008
Targeting the oncogene and kinome chaperone CDC37Phillip J Gray, Thomas Prince, Jinrong Cheng, et al.Plos One|November 19, 2010
Protein kinase A binds and activates heat shock factor 1Ayesha Murshid, Shiuh-Dih Chou, Thomas Prince, et al.Cell Stress & Chaperones|June 14, 2015
Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome AtlasHarvey Schwartz, Brad Scroggins, Abbey Zuehlke, et al.Oncotarget|September 18, 2018
Dual targeting of HSP70 does not induce the heat shock response and synergistically reduces cell viability in muscle invasive bladder cancerThomas Prince, Andrew Ackerman, Alice Cavanaugh, et al.Pageof 3